M. Kraml
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
Papers in
- Pharmacology 16
- Inflammatory mediators and NSAID effects 10
- Pharmacogenetics and Drug Metabolism 10
- Drug-Induced Hepatotoxicity and Protection 6
- Antibiotics Pharmacokinetics and Efficacy 5
-
- Analytical Methods in Pharmaceuticals 12
- Co-authors
- D. Dvornik (27 shared papers)J.-E. Dubuc (18 shared papers)DAVID ROY HICKS (15 shared papers)Jehan F. Bagli (4 shared papers)Roger Gaudry (6 shared papers)Morris L. Givner (4 shared papers)Mitchell N. Cayen (9 shared papers)William T. Robinson (6 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (7 papers)Clinical Biochemistry (7 papers)Journal of Medicinal Chemistry (5 papers)Experimental Biology and Medicine (3 papers)Xenobiotica (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
M. Kraml
66 papers receiving 994 citations
Peers
Comparison fields: 5 of 116
- Pharmacology 173
- Pharmacology 206
- Analytical Chemistry 106
- Biochemistry 74
- Pharmaceutical Science 55
Countries citing papers authored by M. Kraml
This map shows the geographic impact of M. Kraml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kraml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kraml more than expected).
Fields of papers citing papers by M. Kraml
This network shows the impact of papers produced by M. Kraml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kraml. The network helps show where M. Kraml may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Kraml, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1966 | 216 | |
| 2 | 1963 | 124 | |
| 3 | 1994 | 72 | |
| 4 | 1981 | 52 | |
| 5 | 1964 | 48 | |
| 6 | 1966 | 46 | |
| 7 | 1968 | 34 | |
| 8 | 2017 | 33 | |
| 9 | 1964 | 33 | |
| 10 | 1964 | 28 | |
| 11 | 1967 | 27 | |
| 12 | 1988 | 25 | |
| 13 | 1966 | 24 | |
| 14 | 1984 | 24 | |
| 15 | 1962 | 22 | |
| 16 | 2016 | 21 | |
| 17 | Gastrointestinal absorption of griseofulvin. II. Influence of particle size in man. | 1962 | 19 |
| 18 | 1955 | 19 | |
| 19 | 1983 | 19 | |
| 20 | 1963 | 18 |
About M. Kraml
M. Kraml is a scholar working on Pharmacology, Analytical Chemistry, Pharmacology, Molecular Biology and Biochemistry, having authored 67 papers that have together received 1.3k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (12 papers), Cholesterol and Lipid Metabolism (10 papers), Inflammatory mediators and NSAID effects (10 papers), Pharmacogenetics and Drug Metabolism (10 papers), Steroid Chemistry and Biochemistry (6 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Pharmacology (173 citations), Pharmacology (206 citations), Analytical Chemistry (106 citations), Biochemistry (74 citations) and Pharmaceutical Science (55 citations). M. Kraml has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include D. Dvornik, J.-E. Dubuc, DAVID ROY HICKS, Jehan F. Bagli, Roger Gaudry, Morris L. Givner, Mitchell N. Cayen, William T. Robinson, Leslie G. Humber and Eckhardt S. Ferdinandi. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical Biochemistry, Journal of Medicinal Chemistry, Experimental Biology and Medicine and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.